Evaluation of the neurotropic activity of the phytocomposition «Memoris»

Background. Matters of developing new medicinal drugs with nootropic action require systematization of our knowledge as well as conducting of experimental and clinical research.
The aim. Evaluation of the neurotropic activity of the phytocomposition “Memoris”.
Materials and methods. Research is performed on male Wistar rats. Results were evaluated after the end of 14-day-old intake of studied phytocomposition and reference drug Cortexin. Neurotropic activity was measured by tests in open field, elevated plusmaze and Morris water maze. Serotonin, noradrenaline and dopamine content were defined by HPLC-MS/MS.
Results. Under the influence of “Memoris” composition the significant enhancement of locomotor activity in central zone of the open field apparatus had been achieved. This enhancement manifested in statistically significant increase in number of crossed squares, time of movement and time of immobility within central part. Administration of the phytocomposition increased the time rats spent in open arms and in the center of the plus-maze, increased number of head-dips and decreased number of entrances into enclosed arms. Training in the Morris water maze with hidden platform demonstrated statistically significant decrease of latent period of platform search in rats which received phytocomposition and Cortexin by the second day of testing (in control group rats – by the third day). At the day 2 of testing, the time of platform search was statistically significantly different in the groups of rats which received phytocomposition and Cortexin as compared to the control group. Under the influence of “Memoris” phytocomposition increase of serotonin (by 92 %, р = 0,001) and dopamine (by 57 %, р < 0,001) content in hypothalamus, as well as decrease of noradrenaline (by 17 %, р = 0,002) content in hypothalamus were observed.
Conclusion. Phytocomposition “Memoris” has anxiolytic effect comparable to that of Cortexin, increases capabilities for associative learning in rats, affects the concentration of important neurotransmitters – serotonin, dopamine and noradrenaline.

1. Voronina TA. Cognitive impairment and nootropic drugs: mechanism of action and spectrum of effects. Neurochemical journal. 2023; 17(2): 180-188. doi: 10.1134/S1819712423020198

2. Fedorov VN, Petrovsky AK, Vdovichenko VP, et al. Problems of classification and characteristics of neurotropic agents used for the treatment of cerebrovascular disorders. Medicinskayaetika. 2022; 10(1): 25-33. (In Russ.).

3. Shabanov PD. Origins and background for the creation of the Nootropics concept. Neurochemical Journal. 2023; 17(2):163-168. doi: 10.1134/S1819712423020125

4. Malik M, Tlustosh P. Nootropic herbs, shrubs and trees as potential enhancers of cognitive functions. Plants. 2023; 12(6): 1364. doi: 10.3390/plants12061364

5. Belyakov VI, Gromova DS, Popova NR, Myakisheva YuV. Modern methods of studying the behavior of rodents in model biomedical studies (review of the problem). Sovremennye voprosy biomediciny. 2022; 6(4): 13-22. (In Russ.). doi: 10.51871/2588-0500_2022_06_04_1

6. Ivlieva AL, et al. Methodological features of the application of Morris water maze for estimation of cognitive functions in animals. Russian journal of physiology. 2016; 102(1): 3-17. (In Russ.).

7. Mironov AN. Guidelines for conducting preclinical research of medicines. M.: Gryph and K publishing House. M.: Izd-voGrifi K, 2013. – 944. (In Russ.).

8. Khavinson VKh. Peptide medicines: past, present, future. Clinical Medicine (Russian Journal). 2020; 98(3): 165-177. (In Russ.). doi: 10.30629/0023-2149-2020-98-3-165-177

9. Zhalsrai A, Sanzhieva LTs. The Study of the Neuroprotective Effect of the Extract from Chelidonium Majus L. in Vitro. Acta Biomedica Scientifica. 2019; 4(2): 106-113. (In Russ.). doi: 10.29413/ABS.2019-4.2.15

10. Mendzheritsky AM, Karantysh GV, Abramchuk VA, Ryzhak GA, Demyanenko SV. Effect of cortexin and pinealon on the content of monoamines in the rat brain. News of higher educational institutions. North Caucasian region. Natural sciences. 2012; 4: 65-69. (In Russ.).

11. Kulichenko EO, et al. Effect of wild grape seed extract (Vitis vinifera subsp. Sylvestris) on changes in neurotransmitter systems of the brain against the background of mitochondrial complex IV activity deficiency. Kardiovaskulyarnaya terapiya i profilaktika. 2023; 22(S6): 87-87. (In Russ.).

12. Jalsrai A, Biswas A, Suslov NI, Martin JV. Neuropsychopharmacological profile of Astragalus membranaceous var. mongholicus. Journal of Traditional Chinese Medical Sciences. 2019; 6(3): 254-262. doi: 10.1016/j.jtcms.2019.08.002

13. Chong PS, et al. Therapeutic potential of Hericium erinaceus for depressive disorder. International journal of molecular sciences. 2020; 21(1): 163. doi: 10.3390/ijms21010163

14. Yassin NAZ, El-Shenawya SMA, Mahdyb KA, Goudad NAM, Married AEH, Farragc ARH, et al. Effect of Boswellia serrata on Alzheimer′ s disease induced in rats. Journal of the Arab Society for Medical Research. 2013; 8(1): 1-11. doi: 10.7123/01.JASMR.0000429323.25743.cc

15. Chiu CH, Chyau CC, Chen CC, Lee LY, Chen WP, Liu JL, et al. Erinacin A-enriched Hericium erinaceus mycelium produces antidepressant-like effects via modulation of BDNF/PI3K/Akt/GSK-3β signaling in mice. Int. J. Mol. Sci. 2018; 19(2): 341. doi: 10.3390/ijms19020341

16. Sethi P, Sidharth M, Zuber K, Swesha C. Acetyl-11-keto-beta boswellic acid (AKBA) modulates CSTC-pathway by activating SIRT-1/Nrf2-HO-1 signalling in experimental rat model of obsessive-compulsive disorder: Evidenced by CSF, blood plasma and histopathological alterations. Neurotoxicology. 2023. 98: 61-85. doi: 10.1016/j.neuro.2023.08.001